Skip to main content
Premium Trial:

Request an Annual Quote

Linkage Biosciences Raises $2M in Series A Round

NEW YORK (GenomeWeb News) – Linkage Biosciences has raised $2 million in a Series A round of financing, the molecular diagnostics firm said today.

Linkage Bio said the funding round was led by Greenhouse Capital Partners and James R. Fisher, managing member of Fisher Capital Corp. II, a firm that works exclusively with Kohlberg Kravis Roberts.

The firm expects to use the proceeds to support continued development and marketing of Linakge Bio's molecular diagnostic products. It is focused on human leukocyte antigen typing for organ transplantation but also is developing products for other transplant diagnostics and complex genetic disorders.

San Francisco-based Linkage Bio also said that Rebecca Bishop, who is an executive at Affymetrix, and Pascal Villiger of CalSTRS' private equity division, have joined its board of directors.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.